Eastman Chemical Company (EMN) Q4 2024 earnings summary

Executive summary

• Delivered strong earnings, cash flow, and specialty volume/mix growth in 2024, with significant recovery in Advanced Materials and Additives & Functional Products, and a 190-basis-point adjusted EBIT margin improvement for the year.

• Kingsport methanolysis facility operated well, positioning for $75M–$100M incremental EBITDA in 2025 and advancing circular economy leadership.

• Returned approximately $700 million to shareholders via dividends and share repurchases in 2024.

• Cost reduction initiatives targeting $50 million in 2025 are underway to enhance competitiveness.

• Positioned as a leader in circularity, with continued investments in innovation and operational excellence.

Financial highlights

• FY24 revenue was $9.38B, up 2% year-over-year; adjusted EBIT was $1.30B, up from $1.10B in FY23; adjusted EBIT margin improved to 13.8% from 11.9%.

• Adjusted EPS for FY24 was $7.89, up 23% from $6.40 in FY23.

• Operating cash flow for 2024 was $1.3B; 2025 forecast is also $1.3B, as EBITDA growth is offset by higher cash taxes.

• FY24 share repurchases totaled $300 million; total capital returned to shareholders was ~$700 million.

• Q4 2024 sales revenue rose 2% year-over-year to $2.25B.

Outlook and guidance

• 2025 adjusted EPS expected between $8.00–$8.75; operating cash flow projected at ~$1.3B.

• Anticipates $75M–$100M incremental EBITDA from Kingsport methanolysis in FY25.

• Advanced Materials expected to deliver attractive results in 2025, with cost benefits and circular economy ramping up in the second half.

• Volume/mix growth and price discipline anticipated in Q1, with strong order books supporting year-over-year growth.

• FY25 adjusted effective tax rate forecasted at 15%-16%; capital expenditures expected at $700M–$800M.